Iambic Announces Pricing of Initial Public Offering
Iambic official newsroom · Indexed industry source record · Source published: Wed Oct 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 15 2026 00:07:40 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
SAN DIEGO, Calif., October 14, 2026 – Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, today announced the pricing of its initial public offering of 9,375,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Iamb
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.